title: Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
abstract: Three genotoxic mouse carcinogens, 4-chloro-o-phenylenediamine (4-C-o-PDA), 2-nitro-p-phenylenediamine (2-N-p-PDA), and 2,4-diaminotoluene (2,4-DAT), were tested in the Big Blue transgenic mouse mutation assay. Each experiment consisted of a vehicle control group with ten Big Blue C57BL/6 mice, five of either sex, and an equally sized group treated with a high dose of the test chemical. In addition, four animals were treated with the vehicle and six animals with the test compound for the measurement of bromodeoxyuridine (BrdU) incorporation to determine cellular proliferation. Prior to the mutagenicity experiments, the maximally tolerated dose of each compound was determined using nontransgenic C57BL/6 mice. Based on these results the doses used in the main study were 200 mg/kg/day for 4-C-o-PDA, 150 mg/kg/ day for 2-N-p-PDA, and 80 mg/kg/day for 2,4-DAT. Animals were treated for 10 days over a 2 week period and were killed 10 days after the ast treatment. In an additional experiment with 2,4-DAT, animals were killed 28 days after treatment. Since all three chemicals are liver carcinogens in the mouse, the DNA of the liver was analyzed using the standard procedures for the Big Blue assay. Hepatocyte proliferation was assessed by immunohistochemical detection of proliferating cell nuclear antigen (PCNA) and, in some studies, by measuring BrdU incorporation. 4-C-o-PDA and 2-N-p-PDA did not induce an increase in PCNA expression when measured 10 days after the last treatment. There was no increase in BrdU incorporation immediately after treatment with 4-C-o-PDA or with 2,4-DAT. However, 10 days after the last treatment with 2,4-DAT, a strong mitogenic effect was found with both techniques, i.e., in the PCNA and BrdU assays. 4-C-o-PDA, a liver carcinogen in both genders of mice, induced a small, statistically significant increase of the mutant frequencies in females. No increase was found in males. 2-N-p-PDA, which has been reported to induce liver tumors only in females, was found positive in males and was clearly negative in females. 2,4-DAT, a liver carcinogen in female mice, was positive in females and negative in males when the animals were killed 10 days after the last treatment. After an expression time of 28 days, 2,4-DAT induced a statistically significant increase in both sexes. The effect in females was marginally stronger than after 10 days' expression time and almost identical to the effect observed in males under these test conditions. In conclusion, the experiments showed that the Big Blue assay detects the genotoxicity of the three carcinogenic monocyclic aromatic amines tested. However, it seems that the sex specificity of the carcinogenic effects of these compounds is not reflected by the mutagenicity data in Big Blue mice.
authors.affiliation: Sandoz Pharma Ltd., Basel, Switzerland.
authors.forename: W
authors.initials: W
authors.lastname: Suter
authors.forename: R
authors.initials: R
authors.lastname: Ahiabor
authors.forename: B
authors.initials: B
authors.lastname: Blanco
authors.forename: F
authors.initials: F
authors.lastname: Locher
authors.forename: F
authors.initials: F
authors.lastname: Mantovani
authors.forename: M
authors.initials: M
authors.lastname: Robinson
authors.forename: G
authors.initials: G
authors.lastname: Sreenan
authors.forename: F
authors.initials: F
authors.lastname: Staedtler
authors.forename: T
authors.initials: T
authors.lastname: Swingler
authors.forename: A
authors.initials: A
authors.lastname: Vignutelli
authors.forename: E
authors.initials: E
authors.lastname: Perentes
mesh_terms: D000818:Animals; D001426:Bacterial Proteins / Q000187:drug effects / Q000235:genetics; D001973:Bromodeoxyuridine / Q000378:metabolism; D002273:Carcinogens / Q000633:toxicity; D002455:Cell Division / Q000187:drug effects / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D029968:Escherichia coli Proteins; D005260:Female; D056968:Lac Repressors; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic / Q000235:genetics*; D009152:Mutagenicity Tests / Q000379:methods; D009153:Mutagens / Q000633:toxicity; D009154:Mutation; D010655:Phenylenediamines / Q000633:toxicity*; D018809:Proliferating Cell Nuclear Antigen / Q000276:immunology / Q000378:metabolism; D012097:Repressor Proteins / Q000187:drug effects / Q000235:genetics
chemical_list: D001426:Bacterial Proteins; D002273:Carcinogens; D029968:Escherichia coli Proteins; D056968:Lac Repressors; D009153:Mutagens; D010655:Phenylenediamines; D018809:Proliferating Cell Nuclear Antigen; D012097:Repressor Proteins; C015060:4-chloro-1,2-diaminobenzene; D001973:Bromodeoxyuridine; C010914:2,4-diaminotoluene; C014706:2-nitro-4-phenylenediamine